List of Tables
    Table 1. Late Stage Chronic Kidney Disease Drugs Market Opportunities & Trends in Global Market
    Table 2. Late Stage Chronic Kidney Disease Drugs Market Drivers in Global Market
    Table 3. Late Stage Chronic Kidney Disease Drugs Market Restraints in Global Market
    Table 4. Key Players of Late Stage Chronic Kidney Disease Drugs in Global Market
    Table 5. Top Late Stage Chronic Kidney Disease Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Late Stage Chronic Kidney Disease Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Late Stage Chronic Kidney Disease Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Late Stage Chronic Kidney Disease Drugs Product Type
    Table 9. List of Global Tier 1 Late Stage Chronic Kidney Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Late Stage Chronic Kidney Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Late Stage Chronic Kidney Disease Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Late Stage Chronic Kidney Disease Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Late Stage Chronic Kidney Disease Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Late Stage Chronic Kidney Disease Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. AbbVie Corporate Summary
    Table 31. AbbVie Late Stage Chronic Kidney Disease Drugs Product Offerings
    Table 32. AbbVie Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. Amgen Corporate Summary
    Table 34. Amgen Late Stage Chronic Kidney Disease Drugs Product Offerings
    Table 35. Amgen Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Ardelyx Corporate Summary
    Table 37. Ardelyx Late Stage Chronic Kidney Disease Drugs Product Offerings
    Table 38. Ardelyx Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. AstraZeneca Corporate Summary
    Table 40. AstraZeneca Late Stage Chronic Kidney Disease Drugs Product Offerings
    Table 41. AstraZeneca Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. Deltanoid Corporate Summary
    Table 43. Deltanoid Late Stage Chronic Kidney Disease Drugs Product Offerings
    Table 44. Deltanoid Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 45. Akebia Therapeutics Corporate Summary
    Table 46. Akebia Therapeutics Late Stage Chronic Kidney Disease Drugs Product Offerings
    Table 47. Akebia Therapeutics Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 48. Kyowa Hakko Kirin Corporate Summary
    Table 49. Kyowa Hakko Kirin Late Stage Chronic Kidney Disease Drugs Product Offerings
    Table 50. Kyowa Hakko Kirin Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 51. OPKO Health Corporate Summary
    Table 52. OPKO Health Late Stage Chronic Kidney Disease Drugs Product Offerings
    Table 53. OPKO Health Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 54. Vifor Pharma Corporate Summary
    Table 55. Vifor Pharma Late Stage Chronic Kidney Disease Drugs Product Offerings
    Table 56. Vifor Pharma Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 57. Sanofi Corporate Summary
    Table 58. Sanofi Late Stage Chronic Kidney Disease Drugs Product Offerings
    Table 59. Sanofi Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 60. Shield Therapeutics Corporate Summary
    Table 61. Shield Therapeutics Late Stage Chronic Kidney Disease Drugs Product Offerings
    Table 62. Shield Therapeutics Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 63. Shire Corporate Summary
    Table 64. Shire Late Stage Chronic Kidney Disease Drugs Product Offerings
    Table 65. Shire Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 66. Spectrum Corporate Summary
    Table 67. Spectrum Late Stage Chronic Kidney Disease Drugs Product Offerings
    Table 68. Spectrum Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn), (2017-2022)
    Table 69. ZS Pharma Corporate Summary
    Table 70. ZS Pharma Late Stage Chronic Kidney Disease Drugs Product Offerings
    Table 71. ZS Pharma Late Stage Chronic Kidney Disease Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Late Stage Chronic Kidney Disease Drugs Segment by Type in 2021
    Figure 2. Late Stage Chronic Kidney Disease Drugs Segment by Application in 2021
    Figure 3. Global Late Stage Chronic Kidney Disease Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Late Stage Chronic Kidney Disease Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Late Stage Chronic Kidney Disease Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Late Stage Chronic Kidney Disease Drugs Revenue in 2021
    Figure 8. By Type - Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2017-2028
    Figure 12. US Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2017-2028
    Figure 24. China Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Late Stage Chronic Kidney Disease Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Late Stage Chronic Kidney Disease Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. AbbVie Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Amgen Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Ardelyx Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. AstraZeneca Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Deltanoid Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Akebia Therapeutics Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Kyowa Hakko Kirin Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. OPKO Health Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Vifor Pharma Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Sanofi Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Shield Therapeutics Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Shire Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Spectrum Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. ZS Pharma Late Stage Chronic Kidney Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)